Trial Profile
Regulatory Post Marketing Surveillance of Intelence Tablet
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Etravirine (Primary)
- Indications Acquired immunodeficiency syndrome
- Focus Adverse reactions
- Sponsors Janssen
- 29 Sep 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 11 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jan 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.